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        C-type lectin receptors are predominantly ex-
pressed by DCs and function as pattern recog-
nition receptors by interacting with glycosylated 
moieties on pathogens. This usually results in 
internalization of the pathogen, lysosomal deg-
radation, and subsequent loading of pathogen-
derived peptides into MHC molecules for 
antigen presentation (  1  ). Langerin (CD207) is a 
type II lectin receptor containing only one car-
bohydrate recognition domain (  2, 3  ). Although 
the ligands of langerin have not been clearly 
identifi  ed, langerin has recently been shown to 
bind HIV-1 gp120 through calcium-dependent 
mannose recognition (  4  ). Langerin is also a po-
tent inducer of Birbeck granules, a hallmark of 
epidermal DCs, also called Langerhans cells 
(LCs), which consist of zippered membranes 
that are visible by electron microscopy ( 2  ). Upon 
antigen capture, langerin associates to Birbeck 
granules and facilitates the routing of captured 
mannosylated ligands from the cell surface into 
a nonclassical antigen-processing pathway (  2  ). 
Therefore, expression of the langerin receptor 
is likely to refl  ect a functionally distinct cell 
population with specifi  c antigen uptake and 
processing capacity. 
  Langerin is expressed at high levels on 
mouse and human LCs (  2, 3  ), but is absent on 
dermal interstitial DCs (  5  ), providing a unique 
tool to study the biology of cutaneous DC 
populations. Cutaneous DCs include langerin  +   
MHC class II  +   LCs in the epidermis (  6  ) and 
langerin    –    MHC class II  +   interstitial DCs in the 
dermis (  7  –  10  ). In addition to interstitial DCs, 
the dermis contains migratory langerin  +   MHC 
class II  +   LCs en route to the skin draining LNs 
(DLNs) (  11  –  14  ). In the LNs, DCs are catego-
rized as blood-derived CD8  +   and CD8    –    DCs 
and migratory DCs recruited from the periphery 
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  Langerin is a C-type lectin receptor that recognizes glycosylated patterns on pathogens. 
Langerin is used to identify human and mouse epidermal Langerhans cells (LCs), as well as 
migratory LCs in the dermis and the skin draining lymph nodes (DLNs). Using a mouse 
model that allows conditional ablation of langerin  +   cells in vivo, together with congenic 
bone marrow chimeras and parabiotic mice as tools to differentiate LC- and blood-derived 
dendritic cells (DCs), we have revisited the origin of langerin  +   DCs in the skin DLNs. Our 
results show that in contrast to the current view, langerin  +  CD8    –    DCs in the skin DLNs do 
not derive exclusively from migratory LCs, but also include blood-borne langerin  +   DCs 
that transit through the dermis before reaching the DLN. The recruitment of circulating 
langerin  +   DCs to the skin is dependent on endothelial selectins and CCR2, whereas their 
recruitment to the skin DLNs requires CCR7 and is independent of CD62L. We also show 
that circulating langerin  +   DCs patrol the dermis in the steady state and migrate to the skin 
DLNs charged with skin antigens. We propose that this is an important and previously 
unappreciated element of immunosurveillance that needs to be taken into account in the 
design of novel vaccine strategies. 3134 ORIGIN OF LANGERIN  +   DENDRITIC CELLS | Ginhoux et al.
    Figure 1.         Kinetics of langerin  +  repopulation in the epidermis and in skin DLNs.   6  –  8-wk-old Langerin-DTR/EGFP mice received a single intraperito-
neal injection of DT (1      g) and the kinetics of reappearance of langerin  +   was followed by fl  ow cytometry in the epidermis and the skin DLNs at different 
time points after depletion (Fig. S1). (A, top) Dot plots show I-A  b   and langerin expression (EGFP) among living (DAPI       )  CD45 +   cells in the epidermis at 
different times after DT treatment. The remaining CD45  + I-A b     langerin-EGFP        cells represent dendritic epidermal T cells (DETC). (A, bottom) The percentage 
of cells expressing CD8 and langerin among DAPI       CD11c + I-A b+   DCs is shown for skin DLNs. (B) Graphs in log scale present the kinetics of reappearance of JEM VOL. 204, December 24, 2007 
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the skin and remain of host origin   >  18 mo after initiation of 
the parabiosis (  24  ). Therefore, expression of the congenic allele 
in each parabiont and in recipients of congenic BM grafts can 
be used to trace the blood- versus LC-derived origin of skin 
DLN langerin  +   DCs. We have excluded from our analysis 
LN langerin  lo  CD8  +   DCs, as they are thought to derive from 
blood circulating precursors. In contrast, skin DLN langerin  hi
  CD8    –    DCs are thought to derive exclusively from epider-
mal LCs and were the focus of this study. Our results reveal for 
the fi  rst time the presence in mice of a population of langerin  +   
DCs, independent of LCs, in the dermis and the skin DLNs. 
Our study also reveals that LC-independent langerin  +   DCs 
are recruited from the blood to the dermis in the steady state 
to capture tissue antigens before emigrating to the skin DLNs, 
where they present skin-derived peptide-MHC complexes. 
    RESULTS   
  Repopulation of langerin  +   DCs in skin DLNs precedes 
the repopulation of LCs in the epidermis 
  Injection of DT into Langerin-DTR/EGFP mice leads to 
elimination of langerin  +   DCs in the absence of overt skin or 
systemic toxicity, and therefore can be used to examine the 
repopulation of langerin  +   DCs. As previously described, DT 
eliminated the entire LC pool in the epidermis, in addition to 
langerin  lo  CD8  +   DCs and langerin  hi  CD8    –    DCs in the skin 
DLNs (  Fig. 1, A and B  ).   LCs were totally eliminated 2 d after 
DT injection and remained absent   >  14 d after treatment in 
the epidermis (  Fig. 1, A and B  ). Langerin  +   DCs in the skin 
DLNs were also effi   ciently depleted after DT, but in contrast 
to LCs, their repopulation occurred much earlier (  Fig. 1, 
A and B  ). Langerin  +   DCs in the skin DLNs include CD8  +   DCs 
and CD8    –    DCs. Langerin  lo  CD8  +   DCs recovered to normal 
levels in   <  5 d after DT administration. Their rapid repopula-
tion after DT administration is consistent with the fact that 
langerin  lo  CD8  +   DCs are thought to derive from circulating 
precursors with a turnover time of a few days (  25, 26  ). In 
contrast, langerin  +  CD8    –    DCs, a population that is thought to 
derive exclusively from epidermal LCs, started to repopulate 
the skin DLNs long before LCs reappeared in the epidermis 
(  Fig. 1, A and B ), accounting for 25 –  30% of total langerin  +  CD8    –    
DCs in normal untreated skin DLNs. Langerin  +  CD8    –    DCs 
were not detected in nonskin DLNs, such as mesenteric LNs, 
after DT treatment (unpublished data). Based on these results, 
we conclude that a population of LC-independent langerin  +   
DCs, distinct from CD8  +   DCs, exists in the skin DLNs. The 
level of langerin expression on repopulating DCs in the skin 
DLNs was measured by EGFP fl  uorescence and by langerin 
through the lymphatics (  15  ). In the skin DLNs, migratory 
DCs include langerin  +   LCs and dermal langerin    –    DCs (  14, 16  ). 
However, it is now clear that in mice, langerin expression is 
not restricted to LCs, but is also expressed on CD8  +   DCs. 
Indeed, CD8  +  langerin  lo   DCs are present in all lymphoid or-
gans, including LN, spleen, and thymus (  3, 17, 18  ). In con-
trast to migratory LCs, CD8  +   DCs express much lower levels 
of langerin and lack Birbeck granules, suggesting a non-LC 
origin of these cells (  19  ). Therefore, in skin DLNs, langerin  +   
cells are thought to include CD8  +  langerin  lo   blood-derived 
DCs and CD8    –   langerin  hi   LC-derived DCs. Langerin expres-
sion has also been recently identifi  ed on DCs in the lung mucosa 
and vascular wall (  20  ) and in the gut serosa (  21  ). 
  Although the mechanisms that regulate the traffi   cking of 
tissue DCs to the DLN during infl  amed conditions have been 
well studied (  22  ), much less is known about the traffi   cking of 
DC precursors from the blood to tissue and from tissue to 
DLN in the steady state. In this study, we have revisited the 
origin and homeostasis of langerin  +   DCs in the skin DLNs in 
the absence of overt tissue injury. To examine the homeosta-
sis of langerin  +   DCs, we used a recently described mouse 
model that allows the specifi  c depletion of langerin  +   cells, 
while sparing other DC populations. This model consists of 
a knock-in mouse expressing enhanced GFP (EGFP) fused 
with a diphtheria toxin (DT) receptor (DTR), under the con-
trol of the langerin promoter (Langerin-DTR/EGFP) on the 
C57BL/6 background (  18, 23  ). Administration of DT leads 
in 24 h to the elimination of all langerin  +   cells, including 
LCs, without aff  ecting the langerin    –    DC compartment and 
without skin or systemic toxicity (  18, 23  ). After toxin treatment, 
LCs repopulate the epidermis in 6  –  8 wk, off  ering a window 
of time to investigate the relative contribution of DC precur-
sors to the skin DLN DC compartments (  18, 23  ). The original 
description of this model showed that the repopulation of 
langerin  +   DCs in the skin DLNs precedes LC repopulation in 
the epidermis by weeks (  18, 23  ). Intrigued by these results, we 
sought to further clarify the origin and the homeostasis of 
skin DLN langerin  +   DCs. 
  We have previously used congenic parabiotic pairs and 
congenic BM chimeric mice as tools to diff  erentiate epider-
mal LCs from circulating DC precursors. We have established 
that in mice that have been lethally irradiated and reconsti-
tuted with donor congenic BM, epidermal LCs remained of 
host origin throughout life, despite a full donor engraftment 
in the blood (  24  ). We also demonstrated that in congenic 
parabiotic mice that share the same blood circulation but 
separate organs for long period of time, LCs do not mix in 
LCs in the epidermis and CD8       langerin +   (   ) versus CD8  + langerin lo   (   ) in the skin DLNs. Mean values (  ±   the SD) are shown. (right) Histogram shows the 
percentage of CD8       langerin +   (mean values   ±   the SD) among CD11c  + I-A b+   cells before and after DT treatment (DAY14). (C) Overlaid histograms show the 
langerin levels of expression measured either by EGFP fl  uorescence (top) or langerin intracellular staining (bottom) in skin DLN CD11c  + I-A b+   CD8        langerin +  
cells before and after DT treatment (DAY14). C57BL/6 control and isotype control are shown in black for Langerin-EGFP or langerin intracellular staining, 
respectively. Representative data from three independent experiments are shown. Each experiment included at least three separately analyzed mice per 
time point; error bars represent the SD between the results obtained from each of the three mice. (D) Double immunostaining (B220 in blue and langerin 
in red) of skin DLNs from Langerin-DTR/EGFP (Langerin-EGFP in green) before and after DT treatment (DAY14). Fig. S1 is available at http://www.jem.org/
cgi/content/full/jem.20071733/DC1. Bars: (top) 200      m; (bottom) 50      m.   
 3136 ORIGIN OF LANGERIN  +   DENDRITIC CELLS | Ginhoux et al.
intracellular staining. LC-independent langerin  +   DCs in the 
skin DLNs expressed higher levels of langerin compared with 
CD8  +   DCs and similar levels compared with skin DLN lan-
gerin  +   DCs in untreated mice (  Fig. 1 C  ). Using immuno-
staining and confocal analysis of DT-treated skin DLNs, we 
were able to visualize in situ the presence of LC-independent 
langerin  +   DCs in the T cell areas of the skin DLNs 2 wk after 
DT, a time when no LCs are present in the skin (  Fig. 1 D  ). 
  The repopulation of langerin  +  CD8    –    DCs in skin DLNs 
correlates with the recruitment of circulating langerin  +   DCs 
to the dermis 
  Langerin  +  CD8    –    DCs in the skin DLNs can derive either from 
the skin or from blood circulating precursors that enter 
direc  tly into the LN from the blood. Because LCs are absent 
when langerin  +  CD8    –    DCs reappear in the skin DLNs, we looked 
for langerin  +   DCs in the dermis. We detected langerin  +   DCs 
in the dermis long before LCs reappeared in the skin (  Fig. 2, 
A and B  ).   Dermal langerin  +   DCs appeared around day 5 and 
increased up to day 10 after DT injection, after which they 
remained stable in the dermis, reaching 20% of total dermal 
langerin  +   cells, 10% of total dermal DCs, and 2% of total der-
mal leukocytes. 
  Dual origin of langerin  +  CD8    –    DCs in parabiotic animals 
  The aforementioned results suggest that a population of 
langerin  +   DCs, independent of LCs, resides in the dermis and 
in the skin DLNs. To directly examine the origin of skin DLN 
langerin  +   DCs, we used parabiotic mice in which C57BL/6 
CD45.2  +   mice were paired with congenic CD45.1  +   mice so 
that they shared the same blood circulation, but separate or-
gans, for prolonged periods of time. As previously described, 
epidermal LCs remained of recipient origin   >  6 mo after para-
biosis, which is consistent with their origin from skin-resident 
precursors (  Fig. 3, A and B  ).   Therefore, the presence of 
CD45.1  +  langerin  +   DCs in the dermis of the CD45.2  +   parabi-
ont should establish their independence from LCs and their 
recruitment from the blood to the dermis in the steady state. 
As shown in   Fig. 3  , we were able to detect blood-derived 
langerin  +  CD8    –    DCs in the skin (  Fig. 3, A and B  ) and the skin 
DLNs (  Fig. 3, C and D  ) of each parabiont. Total dermal DC 
chimerism was low, but signifi  cant, compared with LC chi-
merism as previously described ( 27  ), refl  ecting either prolonged 
or partial self-replenishment (  27  ) or, as recently suggested, an 
uneven distribution of DC precursors (  26  ). Nevertheless, the 
presence of donor-derived dermal langerin  +   DCs suggests 
that, in contrast to LC-derived dermal DCs, dermal langerin  +   
DCs can originate from blood-derived precursors in the steady 
state. Interestingly, the chimerism of langerin  +   DCs was lower 
than langerin         DCs. Because host langerin  +   DCs consist of a 
mixture of dermal langerin  +   DCs and migrating LCs, it is 
likely that the lower chimerism of langerin  +   compared with 
langerin    –    DCs refl  ects the contribution of migrating LCs. 
Therefore, to better reveal the recruitment of blood-derived 
langerin  +   cells to the skin and to the skin DLNs, we parabi-
osed Langerin-DTR/EGFP CD45.2  +   C57BL/6 animals 
with CD45.1  +   C57BL/6 and followed the repopulation of 
langerin  +   DCs in the CD45.2  +   parabionts at diff  erent times 
after DT treatment. 2 d after DT injection, langerin  +   DCs 
were eliminated from the skin and the skin DLNs of the 
CD45.2  +   Langerin-DTR/EGFP parabionts (unpublished data). 
18 d after DT administration, a time point where LCs are absent 
(  Fig. 3 E  , top), the percentage of donor CD45.1  +  langerin  +   
DCs increased to the level of langerin    –    DCs in the dermis 
    Figure 2.         Kinetics of langerin  +  repopulation in the dermis.   Kinetics of reappearance of langerin  +   DCs was followed by fl  ow cytometry in the dermis. 
(A) Dots plots show langerin expression (EGFP) among live (DAPI       )  CD45 + I-A b+   cells in the dermis at different times after DT treatment. (B) Graph in log 
scale presents the percentage of I-A  b+   langerin +   DCs among total dermal DAPI       CD45 +   cells  (   ) versus epidermal LCs (    ) at different times after DT treat-
ment. (right) Histogram shows the percentage of I-A  b+   langerin +   DCs  among  DAPI      CD45 +   cells before and after DT treatment (DAY14). Mean values (  ±   the SD) 
are shown. Representative data from three independent experiments are shown. Each experiment included at least three separately analyzed mice per 
time point; error bars represent the SD between the results obtained from each of the three mice.     JEM VOL. 204, December 24, 2007 
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scribed, a few weeks after transplant, most blood leukocytes 
originate from donor BM  –  derived precursors and express 
CD45.1, whereas the majority of epidermal LCs are main-
tained by radioresistant precursors, and remain of host 
(CD45.2  +  ) origin throughout life, in the absence of skin in-
jury (  24  ) (  Fig. 4 B  ).   Using fl  ow cytometry analysis of skin 
samples isolated at diff  erent times after transplant, we found 
that a substantial population of langerin  +   DCs in the dermis of 
BM chimeras expressed donor CD45.1 antigens, suggesting 
that they derived from donor BM-derived circulating precur-
sors and not from the host remaining CD45.2  +   LCs (  Fig. 4, 
A and B  ). Consistent with our results (  Fig. 2  ), this population 
corresponded to     10% of dermal MHC class II  +   cells. Blood-
derived CD45.1  +  langerin  +   DCs in the dermis were also MHC 
class II  +  , CD11c  int  , CD11b  +  , CX  3  CR1    –   , CD8    –   , a phenotype 
similar to that expressed by classical LCs with the exception 
(  Fig. 3, E and F  , bottom) and in the skin DLNs (  Fig. 3, G and H  ) 
of the CD45.2  +   Langerin-DTR/EGFP parabionts. These re-
sults establish that in the steady state, circulating langerin  +   DCs 
are recruited to the dermis and to the skin DLNs indepen-
dently of LCs. 
  The origin of langerin  +  CD8    –    DCs in congenic BM chimeras 
  Congenic BM chimeric mice provide another model in 
which the CD45 congenic allele can be used to distinguish 
LCs from blood-derived DCs in the skin DLNs. The advan-
tage of this model is that the majority of circulating leuko-
cytes express the congenic allele, whereas in parabiotic mice, 
no more than 50% of leukocytes express the congenic allele 
(  26  ). To generate congenic BM chimeras, C57BL/6 CD45.2  +   
mice were lethally irradiated and reconstituted with BM cells 
isolated from C57BL/6 CD45.1  +   mice. As previously de-
    Figure 3.         Homeostasis of langerin  +   DCs in parabiotic mice.   Each parabiotic pair consisted of one CD45.1  +   C57BL/6 mouse with either a CD45.2  +  
C57BL/6 mouse (A  –  D) or CD45.2  +   Langerin-DTR/EGFP C57BL/6 mouse for DT depletion experiments (E  –  H). (A  –  D) Skin and skin DLN chimerism was exam-
ined by fl  ow cytometry in untreated CD45.2  +   parabiont of a CD45.1/CD45.2 parabiotic pair at 2 mo after the initiation of parabiosis. (A) Dot plots show 
the chimerism of gated LCs (CD45  + I-A b+   langerin +  ) in the epidermis (top) and the chimerism of gated langerin   –    and  langerin +   DCs  (CD45 + I-A b+  ) in the 
dermis (bottom). (B) Bar graphs show the percentages of donor (CD45.1  +  )-derived cells among gated LCs (top) and langerin   –    or  langerin +   dermal  DCs 
(bottom). (C) Dot plots show the percentage of host and donor cells among gated CD11c  +   I-A b+   DCs,  langerin  –  CD8  –    DCs and langerin  + CD8  –    DCs. (D) Mean 
values of langerin   –    versus  langerin +   DCs chimerism in CD45.2  +   parabionts. Similar data are found in the skin and skin DLNs of untreated CD45.2 Langerin-
DTR/EGFP parabionts (unpublished data). Representative data from 5 separate experiments are shown. Each experiment included two to four mice. Skin 
was separately analyzed for each mouse, whereas skin DLNs were pooled (pool of two mice); error bars represent the SD between the results obtained 
from each mouse (skin) or from pooled DLNs (skin DLN). (E  –  H) Similar data to that found in A  –  D was obtained from DT-treated CD45.2  +   Langerin-DTR/
EGFP parabiont of a CD45.1/CD45.2 Langerin-DTR/EGFP parabiotic pair. Data presented are from 18 d after DT treatment, a time when LCs are still de-
pleted (top), whereas langerin  +   dermal DCs are recovered. Representative data from two separate experiments are shown. Each experiment included two 
separately analyzed mice, except for the skin DLNs that were pooled. For the skin, error bars represent the SD between the results obtained from each of 
the two mice.     3138 ORIGIN OF LANGERIN  +   DENDRITIC CELLS | Ginhoux et al.
    Figure 4.         Homeostasis of langerin  +   DCs after congenic BM transplantation.   Lethally irradiated host CD45.2  +  C57BL/6 were transplanted with con-
genic donor CD45.1  +  C57BL/6 BM (CD45.1 into CD45.2 chimeric mice). 2 mo after reconstitution, host versus donor chimerism was measured in the 
 langerin +   DC population in the skin (A and B) and in skin DLNs (D and E). (A) Dot plots show I-A  b   and langerin expression among dermal CD45  +   cells, and the 
host versus donor chimerism of langerin  +   dermal DCs (CD45  + I-A b+  ). (B) Mean values of langerin  +   DCs chimerism in the dermis. LC (CD45  + I-A b+   langerin + ) 
chimerism in the epidermis is shown as control. (C) Expression of different markers was compared by fl  ow cytometry between host remaining (CD45.2  +
 I-A b+   langerin +  ) LCs and donor-derived langerin         or  langerin +   dermal DCs. (D) Dot plots show CD8 versus langerin expression among CD11c  + I-A b+   cells  in 
the skin DLNs and host versus donor chimerism of CD8         langerin +   DCs. (E) Mean values of langerin  +   DC chimerism. (F) Phenotype of donor-derived CD8        
DC langerin  + ,  CD8 +   DC  langerin       , and host remaining LCs. (G) Back skin cross-sections isolated from CD45.2 Langerin-EGFP into CD45.1 chimeric mice 
(left) or the reverse CD45.1 into CD45.2 Langerin-EGFP chimeric mice (right) were stained with anti-langerin antibody. Nuclei were counterstained with 
DAPI. Bar, 50      m. (H) Dermal cell suspensions were prepared from CD45.2 Langerin-EGFP into CD45.1 chimeric mice. Donor langerin  +   dermal DCs were 
sorted on the criteria of CD45.2, I-A  b  , and EGFP expression and harvested onto cytospin slides for langerin staining. Inset shows langerin staining control. 
Bar, 10      m. Representative data from four independent experiments are shown. Each experiment included at least three separately analyzed mice; error bars 
represent the SD between the results obtained from each of the three mice.     JEM VOL. 204, December 24, 2007 
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langerin  +  CD8    –    DCs. These results suggest that circulating 
langerin  +  CD8    –    DCs reach the skin DLNs through the skin and 
not directly from the blood. 
  Mechanisms that regulate the recruitment of circulating 
langerin  +   DCs to the dermis 
  Previous results suggest that circulating DC precursors roll 
continuously along noninfl  amed mouse dermal endothelium 
in vivo, an interaction shown to be strictly dependent on 
  endothelial selectins (  31  ). To examine if endothelial selectins 
play a role in the homeostasis of dermal langerin  +   DCs, we re-
constituted lethally irradiated C57BL/6 mice that lack both 
P- and E-selectins (P/E-selectin KO), or wild-type C57BL/6 
controls with BM cells isolated from congenic CD45.1 +  C57BL/6 
mice. 2 mo after reconstitution, we found that P/E-selectin KO 
have similar numbers of CD45.1  +   circulating B cells, mono-
cytes, and neutrophils compared with wild-type controls, sug-
gesting that absence of P- or E-selectins did not aff  ect BM 
engraftment (unpublished data). In contrast, the percentage of 
dermal langerin  +   DCs in P/E-selectin KO mice was 30  –  50% 
lower than the percentage of dermal langerin  +   DCs in wild-
type mice (  Fig. 5 E  ). Similar results were observed for dermal 
langerin    –    DCs (unpublished data). 
  We previously established that CCR2 chemokine ligands 
are required for the recruitment of circulating dermal DC 
precursors to the skin (  27  ). We also established that CCR2 
and CCR6 chemokine ligands are required for the recruit-
ment of circulating LC precursors and the repopulation of 
LCs in infl  amed skin (  32, 33  ). To examine the role of these 
molecules in the recruitment of circulating donor langerin  +   
DC precursors to the dermis, we reconstituted lethally irradi-
ated CD45.1  +  C57BL/6 mice with a 1:1 mixture of hemato-
poietic progenitors cells that consisted of CD45.2  +   BM cells 
that either lacked CCR2 (CCR2 KO) or CCR6 (CCR6 KO) 
and wild-type CD45.1  +   BM. 2 mo after reconstitution, we 
found that CCR2       /      , CCR6       /      , and wild-type CD45.1  +   
BM gave rise to similar numbers of circulating B cells and 
neutrophils, suggesting that the absence of CCR2 and CCR6 
did not aff  ect BM engraftment (unpublished data). In contrast, 
CCR2       /      CD45.2  +  CD115  +   circulating monocytes repre-
sented 30 –  40% of circulating CD45.2  +  CCR6       /       or CD45.1  +   
wild-type monocytes (unpublished data), confi  rming that ab-
sence of CCR2 expression on hematopoietic progenitors af-
fects monocyte repopulation in the blood (  27, 34  ). We found 
that CCR2       /       dermal langerin  +   DCs were reduced in the 
skin compared with their wild-type counterpart (  Fig. 5 F  ), 
whereas CCR6 KO langerin  +   dermal DCs were not aff  ected 
(  Fig. 5 F  ). Similar results were observed for dermal langerin    –    
DCs (  Fig. 5 F  ). These diff  erences underline the essential role 
of CCR2 in the recruitment of dermal langerin  +   DCs to the 
skin, whereas the role of CCR6 seems to be restricted to the 
repopulation of epidermal LCs. 
  Role of langerin  +  CD8    –    DCs in skin immunity 
  Our results reveal for the fi  rst time that circulating langerin  +   
DC precursors are recruited to the dermis in the steady state 
of the langerin levels, but diff  erent from that of dermal lan-
gerin    –    DCs (  Fig. 4 C  ). We also discovered that, in the skin 
DLNs, an increased proportion of langerin  +  CD8    –    DCs ex-
press CD45.1 (60  –  70%), and therefore are derived from 
blood-precursors and not from epidermal LCs (  Fig. 4, D and E  ). 
Blood- and epidermal-derived langerin  +  CD8    –    DCs were 
  indistinguishable phenotypically and expressed higher levels 
of MHC class II and langerin and lower levels of CD11c 
compared with langerin  lo  CD8  +   DCs (  Fig. 4 F  ). Interestingly, 
langerin expression formed a smear on dermal blood  –  derived 
langerin  +   DCs, which may suggest that the langerin receptor 
was being acquired upon entry in the dermis and up-regu-
lated during the migration to the skin DLNs. These results are 
consistent with the data from a companion paper showing 
that blood-derived langerin  +   DCs that emigrate from skin ex-
plants have similar langerin levels compared with LCs (  28  ). 
Donor-derived langerin  +  DCs were visualized in situ by 
confocal microscopy analysis of skin sections isolated from 
(CD45.2  +  Langerin-EGFP BM→CD45.1  +  C57BL/6) or the 
reverse (CD45.1+C57BL/6 BM→CD45.2+Langerin-EGFP) 
mice chimeras (  Fig. 4 G  ). Donor-derived langerin  +   DCs ap-
pear scattered in the dermis, without any conspicuous local-
ization near the hair follicle. Donor-derived CD45.2  +   MHC 
class II  +   Langerin-EGFP  +   DCs were also purifi  ed by FACS 
and stained for langerin on cytospins (  Fig. 4 H  ). Altogether, our 
results suggest that, although undistinguishable phenotypi-
cally, blood- and epidermal-derived langerin  +  CD8    –    DCs coexist 
in the skin DLNs of BM chimeric mice. 
  Mechanisms that regulate the traffi  cking of langerin  +  CD8    –    
DCs to the skin DLNs 
  The presence of blood-derived langerin  +  CD8    –    DCs in the skin 
DLNs always paralleled their presence in the skin. However, 
the percentage of blood (CD45.1  +  )-derived langerin  +   DCs 
among total langerin  hi   DCs was always higher in the skin DLNs 
compared with the dermis (compare   Fig. 4 B   with   Fig. 4 E  ), 
suggesting that these cells either transit more rapidly than mi-
gratory LCs, but do not accumulate in the skin, or that they 
can also be recruited to the skin DLNs directly from the blood. 
To address these questions, we reconstituted lethally irradiated 
CD45.1  +  C57BL/6 recipient mice with BM cells isolated from 
congenic CD45.2  +   mice that lack L-selectin (CD62L KO) or 
the chemokine receptor CCR7 (CCR7 KO). L-selectin is 
constitutively expressed on most leukocytes and plays an im-
portant role in leukocyte homing into lymphoid tissue from 
the blood (  29  ). CCR7 is a chemokine receptor that plays a 
critical role in the migration of DCs from the skin to the DLNs 
(  30  ); therefore, absence of CCR7 should interfere with the 
migration of DCs from the skin to the skin DLNs. 2 mo after 
reconstitution, the percentage of CCR7 KO and CD62L KO 
circulating langerin  +   DCs in the dermis was similar to their 
wild-type counterpart (  Fig. 5, A and B  ).   In contrast, the per-
centage of CCR7 KO langerin  +  CD8    –    DCs was markedly re-
duced compared with CCR7  +/+   langerin  +  CD8    –    DCs in the 
skin DLNs (  Fig. 5, C and D  ). No diff  erences were observed 
between the percentages of CD62LKO versus CD62L  +/+   3140 ORIGIN OF LANGERIN  +   DENDRITIC CELLS | Ginhoux et al.
    Figure 5.         Mechanisms involved in the recruitment to the dermis and the migration to the skin DLNs of dermal langerin  +   DCs.  (A – D)  Host 
congenic CD45.1  +  C57BL/6 were lethally irradiated and transplanted with donor CD45.2  +   C57BL/6 (Control), CCR7-defi  cient (CCR7 KO), or CD62L-defi  cient 
(CD62L KO) BM. After complete donor engraftment, the chimerism of total langerin  +   cells in the dermis and in the skin DLNs was measured by fl  ow 
  cytometry. (A) Dot plots show CD45.1 (host) versus CD45.2 (donor) expression in langerin  +   dermal DCs from control, CCR7KO, and CD62LKO chimeric mice. 
(B) Mean values (  ±   the SD) of langerin  +   dermal DCs chimerism. (C and D) Same as in A and B, but for CD8       langerin +   DCs in the skin DLNs of control, CCR7 
KO, or CD62L KO groups. (E) Lethally irradiated host wild-type CD45.2  +  C57BL/6 (Control) or CD45.2  +   P/E-selectin  defi  cient (P/E-selectin KO) were lethally 
irradiated and transplanted with congenic CD45.1  +  C57BL/6 BM. After complete donor engraftment, the chimerism of total CD45  + I-A b+   langerin +   DCs  in 
the dermis was measured by fl  ow cytometry. Bar graph shows the chimerism of langerin  +   dermal DCs in control group (black bars) versus P/E-selectin 
KO group (white bars) 2 mo after transplantation. Mean values (  ±   the SD) are shown. (F) CD45.1  +   C57BL/6 were lethally irradiated and reconstituted with 
a mixture of CD45.1  +   WT BM and CD45.2  +   BM isolated from WT, CCR2 KO, or CCR6 KO BM, as described in the Materials and methods. 2 mo after trans-
plant, chimerism of total langerin  +   DCs in the dermis was measured. Bar graph shows the mean value of the percentage of CD45.2  +   cells among langerin  +  
and langerin         dermal DCs in control group (black bars), CCR2 KO group (white bars), and CCR6 KO group (gray bars). Mean values (  ±   the SD) are shown. 
Representative data from two independent experiments are shown. Each experiment included at least three separately analyzed mice; error bars represent 
the SD between the results obtained from each of the three mice.     
or after minor injuries (i.e., DT or radiation injuries). Our 
results also suggest that circulating langerin  +   precursors that 
are recruited to the dermis do not establish in the epidermis, 
but emigrate to the skin DLNs. To examine if blood-derived 
dermal langerin  +   DCs play a role in skin immunity, we sought 
to analyze whether they can capture, process, and present 
skin-derived antigen in the skin DLNs under steady-state 
conditions. To assess antigen presentation, we took advan-
tage of the YAe monoclonal antibody that recognizes an MHC 
class II I-E  –  derived peptide presented in the context of MHC 
class II I-A  b   molecules. We reconstituted lethally   irradiated 
F1 (C57BL/6 I-A  b  –  /  –    x BALB/c I-E  d+  ) recipient mice with 
BM cells isolated from CD45.1  +   C57BL/6 I-A  b+/+   Langerin-
EGFP BM. In transplanted mice, only I-A  b+/+   donor cells, 
and not host residual LC I-A  b     /      , can present I-E  d    –  de-
rived peptide recognized by YAe. In the skin of F1 (C57BL/
6xBALB/c) animals, I-E  d   is expressed by host radioresistant 
LCs (  24  ) and some activated keratinocytes (  35  ) (unpub-
lished data). Therefore, donor I-A  b+/+   DCs should be able to 
present I-E  d    –  derived peptides and stain positive for YAe only 
if they can capture, process, and present skin-derived anti-
gens. We found that, in the dermis, donor-derived circulating JEM VOL. 204, December 24, 2007 
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such as the neck and the back skin. However, the constant 
percentage of donor-derived langerin  +   in skin DLNs draining 
diff  erent parts of the skin, including those containing host LCs 
exclusively, argues against this hypothesis (unpublished data). 
Alternatively, the radiation-induced injuries that might occur 
in transplanted BM chimera mice may also aff  ect the homeo-
stasis of dermal langerin  +   DCs and increase their recruitment 
to the skin DLNs. Another possibility is that blood-derived 
langerin  +   DCs are recruited directly from the blood to the skin 
DLNs. Several lines of evidence argue against this possibility. 
First, the presence of langerin  +  CD8    –    DCs in the skin DLNs 
always paralleled their presence in the skin, with the latter re-
constituting the dermis before the skin DLNs in depletion ex-
periments. Second, their recruitment to the skin DLNs was 
independent of the L-selectin (CD62L), but required the che-
mokine receptor CCR7. CD62L is constitutively expressed on 
most leukocytes, including DC precursors, and plays a critical 
role in the fi  rst steps of leukocyte extravasation from the blood 
to the LN, allowing the rolling of blood leukocytes on high 
endothelial venules (HEVs) (  29  ). CCR7 is the receptor for 
two structurally related chemokines, CCL19 and CCL21 (  37  ). 
CCL19 and CCL21 are expressed by stromal cells within the 
lymphoid T cell zones, and CCL21 is expressed by HEVs and 
at lower levels by the lymphatic endothelium (  38, 39  ). In mice 
lacking CCR7 (  30  ) or CCR7 ligands (  40  ), DCs fail to migrate 
from the skin to the T cell areas of the skin DLNs, providing 
the most compelling evidence for an essential role of CCR7 in 
this process. Altogether, these studies led to the current con-
cept that migrating DCs express CCR7 and become chemo-
tactically attracted to CCL21-expressing lymphatic vessels. The 
migrating DCs reach the subcapsular sinus of the DLNs and 
follow a gradient of CCL21 and CCL19 to move into the 
lymphoid T zone (  38  ). Unlike all other chemokine receptors, 
CCR7 is resistant to ligand-induced down-regulation (  41  ), 
which may explain how DCs can use CCR7 to perform all 
the critical steps of migration. The failure of blood-derived 
langerin  +   DCs to enter the skin DLNs in the absence of CCR7, 
but not in the absence of CD62L, strongly suggests that these 
cells reach the skin DLNs through the skin lymphatics and not 
directly from the HEVs. However, CD8  +   DCs, a population 
thought to be recruited to the LN through the HEVs, were 
also able to reach the skin DLNs in the absence of CD62L; 
however, in contrast to CD8    –    langerin  +   DCs, the lack of 
CCR7 did not aff  ect their recruitment to the skin DLNs (un-
published data). These results were surprising, as we expected 
that, similar to naive T cells (  39  ), expression of CD62L and 
CCR7 would both be required for effi   cient homing to the 
HEVs. However, these data support previous fi  ndings, show-
ing that CD62L is not required for the migration of spleen 
DCs on resting or activated endothelial cells in vitro (  42  ), and 
suggest that other molecules might orchestrate the recruitment 
of blood DCs through the HEVs. A potential candidate might 
be   “  chemerin,  ”   a proteolytically regulated chemoattractant 
protein expressed at high levels by HEVs and shown to che-
moattract in vitro ChemR23  +   DCs, which include human 
blood DCs, but not LCs (  43, 44  ). 
dermal langerin  +   DCs stained positive for YAe, as did langerin    –    
dermal DCs, establishing their capacity to capture and pres-
ent exogenous skin-derived antigens (  Fig. 6, A and B  , top).   
Our results also show that blood-derived dermal langerin  +   
DCs that migrate to the skin DLNs also stain positive for YAe 
(  Fig. 6, A and B  , bottom). A higher percentage of blood-
derived dermal langerin  +   DCs were positive for YAe in the 
skin DLNs compared with the dermis (  Fig. 6, A and B  , bottom), 
suggesting that dermal-derived langerin  +   DCs process and 
present skin-derived antigens en route to the skin DLNs. Similar 
results were obtained when corresponding purifi  ed dermal 
DC populations were examined on cytospins for langerin and 
YAe expression (  Fig. 6 C  ). 
    DISCUSSION   
  Using three separate models to trace the turnover of circulat-
ing leukocytes, our study reveals the presence of a population 
of langerin  +   DCs, independent of LCs, in the dermis and skin 
DLNs of mice in the steady state. 
  We used parabiotic mice to establish the constitutive re-
cruitment of blood-derived langerin  +   DCs to the dermis and 
their subsequent emigration to the skin DLNs. Parabiotic 
mice provide a useful model to study the physiological turn-
over of leukocytes (  36  ). Although recent data suggest that 
circulating DC precursors do not reach complete equilibrium 
in parabionts (  26  ), this model continues to be very useful to 
compare traffi   cking patterns among DC subsets. Parabiotic 
mice are particularly useful to distinguish LC-derived DCs 
from blood-derived dermal langerin  +   DCs in the steady state 
because LCs fail to mix in the epidermis   >  18 mo after the 
parabiosis is established (  24  ). Using the congenic CD45.1 
marker to trace circulating leukocytes in the CD45.2 parabi-
ont, our results reveal that blood-borne dermal langerin  +   DCs 
are constitutively recruited to the dermis and the skin DLNs 
in the absence of overt injuries. Similar results are reported in 
a companion paper (  28  ). In this study, the authors show that 
in congenic BM chimeric mice, langerin  +   DCs express higher 
levels of CD45 compared with LCs and used the levels of 
CD45 expression to identify langerin  +   DCs, independent of 
LCs, in the dermis of naive nontransplanted animals. Alto-
gether, these results strongly support the recruitment of circu-
lating langerin  +   DCs, independent of LCs, to the dermis in 
the steady state. 
  Congenic BM chimeric mice provide another tool to dis-
tinguish LCs from blood-derived DCs, as LCs remain of host 
origin months after transplant despite complete donor-derived 
chimerism in the blood. In this model, blood-derived langerin  +   
DCs were also present in the dermis and accounted for 30% 
of total langerin  +   dermal DCs. Surprisingly, the percentage of 
blood-derived langerin  +   DCs is increased in the skin DLNs, 
reaching up to 60% of langerin  +   DCs. The higher percentage 
of donor-derived langerin  +   DCs in the skin DLNs, compared 
with dermal langerin  +   DCs in congenic BM chimeras, is in-
triguing, and could be partially caused by a minor contribution 
of donor-derived LCs, which represent 5  –  10% of total LCs in 
areas of skin exposed to fi  ght- or grooming-related injuries, 3142 ORIGIN OF LANGERIN  +   DENDRITIC CELLS | Ginhoux et al.
    Figure 6.         Phagocytic processing and migration capacities of blood-derived langerin  +   DCs.   Lethally irradiated F1 (C57BL/6 I-A  b    /    /BALB/c  I-E d+ ) 
mice were reconstituted with BM cells isolated from donor Langerin-EGFP CD45.1  +   C57BL/6  I-A b+   mice. (A, top) Overlaid histograms show YAe staining on 
gated host LCs (CD45.2  + CD11c + Langerin-EGFP  –   ), donor langerin  +   dermal DCs (CD45.1CD11c  + Langerin-EGFP +  ), and donor langerin         dermal  DCs 
(CD45.2  + CD11c + Langerin-EGFP  –   ). LCs isolated from F1 (C57BL/6 I-A  b+/+ /BALB/c  I-E d+  ) mice were used as controls. (A, bottom) YAe staining is shown for 
host LC-derived DCs (CD45.2  + CD11c + Langerin-EGFP       ), donor langerin  +   DCs  (CD45.1 + CD11c + CD8a      Langerin-EGFP +  ), and donor langerin         DCs  (CD45.2 + CD
11c  + CD8      langerin       ) in the skin DLNs. Corresponding YAe isotype control (blue) and WT F1-positive control (green) are shown. (B) Mean values (  ±   the  SD) 
of the percentage of YAe  +   cells among donor langerin  +   or  langerin        DCs in the dermis and skin DLNs. Representative data from two independent experi-
ments are shown. Each experiment included at least three separately analyzed mice; error bars represent the SD between the results obtained from each 
of the three mice. (C) Host LCs in the epidermis, donor langerin  +  , or langerin         DCs in the dermis, LC-derived DCs, or donor langerin  +   or  langerin        DCs  in 
the skin DLNs were purifi  ed by cell sorter and stained on cytospin for YAe and langerin as described in Materials and methods. Insets show YAe isotype 
control for each tested DC population. Dashed white lines indicate where cells were spliced from different fi  elds to present more cells within a panel. 
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CCR2 also plays a critical role in the release of BM mono-
cytes into the bloodstream (  34  ), and mice reconstituted with 
CCR2       /       BM have a decreased number of circulating mono-
cytes ( 27  ). Therefore, it is possible that the decrease of CCR2       /       
blood-derived langerin  +   DCs in the dermis refl  ects a reduced 
capacity for CCR2       /       monocytes to reach the peripheral 
blood and diff  erentiate into dermal DCs in the quiescent skin. 
These results support the recent findings that monocytes 
participate in DC homeostasis in peripheral tissues, but not in 
lymphoid organs (  47  ), and the role of CCR2 in the develop-
ment of nonlymphoid DC populations other than skin is cur-
rently being analyzed in the laboratory. 
  Consistent with previous studies, our results show that af-
ter systemic depletion of langerin  +   cells in vivo, the repopula-
tion of dermal and skin DLN langerin  +   DCs precedes the 
repopulation of epidermal LCs (  18, 23  ). We also demonstrate 
that dermal langerin  +   DCs, independent of LCs, participate in 
the repopulation of the langerin  +   DC pool in the skin DLNs, 
whereas the epidermis remains empty of LCs. It is intriguing 
that langerin  +   dermal DCs migrate to the skin DLNs before 
seeding an epidermis depleted of LCs, suggesting that blood-
derived langerin  +   DCs cannot diff  erentiate into LCs in vivo. 
Another possibility is that the toxin used to deplete langerin  +   
cells leads to infl  ammatory signals that trigger the migration of 
blood-derived dermal langerin  +   DCs to the skin DLNs before 
they can reach the epidermis. This is unlikely because we have 
shown that circulating LC precursors can seed an infl  amed 
epidermis and diff  erentiate into LCs (  33  ). In addition, we and 
others have not detected signs of skin infl  ammation or injuries 
after DT injection ([  18  ] and unpublished data). A more likely 
explanation is that in vivo conditional LC ablation with DT 
frees available LC niches, but fails to induce epidermal injury 
signals, precluding the recruitment of blood-derived precur-
sors to the epidermis. It will be interesting to examine if in-
duction of infl  ammatory cytokines and chemokines in the 
epidermis after DT treatment accelerates the recruitment of 
dermal langerin  +   DCs to the epidermis. If this is true, these 
data, together with our previous data showing that monocytes 
are the precursors of LCs in infl  amed skin, will support the 
hypothesis that monocytes are constitutively recruited to the 
dermis where they diff  erentiate into langerin  +   DCs dedicated 
to survey the epidermis or the dermal  –  epidermal junction. 
  The acquisition of the langerin receptor on skin-infi  ltrating 
monocytes or a committed DC precursor might represent the 
signature of a   “  LC-like  ”   diff  erentiation program induced by 
environmental factors such as TGF     , for example (  48  ). Sup-
porting this hypothesis is our fi  nding that dermal langerin  +   DCs 
seem to progressively acquire the LC marker langerin while 
losing the monocyte marker CX3CR1, a marker that is also 
absent on LCs, but partially expressed by dermal langerin    –    DCs 
(  Fig. 4 C  ). Whether dermal langerin  +   and dermal langerin    –    DCs 
represent the progeny of a precursor that follows a separate dif-
ferentiation pathway, with the dermal langerin  +   DCs being an 
intermediate precursor to LCs, is plausible, but diffi   cult to test 
because of the limitation of an experimental system dealing 
with a low number of cells. More information will be needed 
  We also examined the mechanisms that regulate the re-
cruitment of blood-derived langerin  +   DCs to the dermis. Our 
data suggest that blood-derived langerin  +   DCs use E- and 
P-selectin to enter the skin in the absence of skin injuries. These 
data are consistent with a previous study showing that human 
CD34  +  -derived DCs injected into immunocompromised mice 
roll continuously along noninfl  amed mouse dermal endo-
thelium in an E- and P-selectin  –  dependent manner (  31  ). 
Our data also show that CCR2 controls the recruitment of 
blood-derived langerin  +   DCs to the quiescent dermis. Ex-
pression of CCR2 (  45  ) on circulating leukocytes was shown 
to be required for the repopulation of LCs (  32, 46  ) and dermal 
langerin    –    DCs in infl  amed skin (  27  ). Our results represent the 
fi  rst indication for a role of CCR2 in cutaneous DC homeo-
stasis in the absence of overt skin infl  ammation. However, it 
remains possible that the transplant model used to reveal the 
role of CCR2 might lead to x ray  –  induced skin injuries, trig-
gering the release of CCR2 ligands and the recruitment of 
circulating DCs that will not be encountered in the steady state. 
    Figure 7.         Origin of langerin  +   DC in mice.   This diagram illustrates a 
hypothetical view on cutaneous DC differentiation pathways in mice in 
the steady state. Epidermal LCs are maintained by radioresistant hemato-
poietic progenitors that have taken residence in the skin before birth, 
whereas the majority of dermal DCs derive from circulating DC precur-
sors. Our results now suggest that circulating blood-derived CCR2  +   DCs 
are constitutively recruited to the dermis. E- and/or P-selectin direct this 
recruitment in transplanted animals, and studies are conducted in the 
laboratory to examine if this is also true in nontransplanted mice. In 
response to cutaneous factors, CCR2  +   DCs differentiate into dermal 
 langerin +   DCs, but might also be able to differentiate into dermal 
 langerin  –  CX3CR1 +/       DCs. Dermal langerin  +   DCs transit, but do not accu-
mulate in the dermis, where they capture skin antigens, before emigrating 
to the skin DLNs to present skin-derived peptides in the context of MHC 
molecules. Both LCs and dermal DCs require CCR7 to migrate to the T 
cells area of skin DLNs. In the skin DLNs, dermal langerin  +   DCs are undis-
tinguishable from LC-derived DCs, and they are characterized as CD8   –
  langerin + CD11c lo  , but differ from blood-derived CD8  +   langerin lo CD11 hi   DCs. 
Whether CCR2  +   blood precursors that give rise to dermal langerin  +   DCs 
and contribute to CD8   –  langerin +   CD11c lo   in the skin DLNs represent a 
committed DC   precursor or a circulating monocyte is currently under 
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were analyzed with FlowJo software (Tree Star, Inc.). Fluorochrome- or 
biotin-conjugated monoclonal antibodies specifi  c to mouse B220 (RA3-6B2), 
CD8a (53  –  6.7), I-A  b   (AF6-120.1), IA/IE (M5/114.15.2), CD11b (M1/70), 
CD11c (N418), CD45 (30F11), CD45.1 (A20), CD45.2 (104), CD115 
(AFS98), Gr-1Ly6C (1A8), Gr-1Ly6C/G (RB6-8C5), CD3 (17A2), CD4 
(clone L3T4), anti  –  mouse E     52-68 peptide bound to the I-A  b  /MHC Class II 
(YAe), the corresponding isotype controls, and the secondary reagents (allo-
phycocyanin, peridinin chlorophyll protein, and phycoerythrin  –  indotricarbo-
cyanine  –  conjugated streptavidin) were purchased either from BD Biosciences 
or eBioscience. For YAe staining, naive untreated cells from C57BL/6 mice 
that lack I-E molecules were used as negative controls, and cells from C57BL/6 
BALB/c F1 mice were used as positive controls. Anti  –  mouse CD16-32 (BD 
Biosciences) and biotinylated mouse IgG2b isotype control (BD Biosciences) 
were used to block Fc III/II receptors and as a YAe isotype control antibody, 
respectively. F4/80 (A3-1) was purchased from Serotec. Polyclonal antibody 
to langerin was purchased from Santa Cruz Biotechnology. Intracellular stain-
ing against langerin was performed with the BD Cytofi  x/Cytoperm kit (BD 
Biosciences) according to the manufacturer  ’  s protocol. For cytospin immuno-
staining, stained cell suspensions were sorted using an inFlux cell sorter 
(Cytopeia, Inc.) and achieve 97  –  99% purity. 
  Transplantation of BM cells.     8-wk-old recipient CD45.2  +   or CD45.1  +   
C57BL/6 mice were lethally irradiated with 1,200 rads, delivered in 2 doses 
of 600 rads each, 3 h apart, and were injected i.v. with 10  6   BM cells obtained 
from congenic CD45.1  +   or CD45.2  +   C57BL/6 adult mice, respectively. 
To address the role of CCR2 and CCR6 in dermal DC langerin  +/       homeostasis, 
lethally irradiated CD45.1  +   C57BL/6 mice were reconstituted with a 1:1 
mixture of WT CD45.1  +   BM cells and CD45.2  +   BM isolated from WT, 
CCR2 KO, or CCR6 KO mutant mice. In all transplanted mice, levels 
of blood donor chimerism were analyzed by measuring the percentage of 
donor cells among total B220  +   B cells, Ly6C/G  +  CD115    –    granulocytes, and 
CD115  +   monocytes in the blood 3 wk after transplantation. 
  Preparation of epidermal and dermal cell suspension.     Skin cell sus-
pensions were isolated as previously described (  24  ) and were analyzed by 
fl  ow cytometry. In brief, mouse ears were split in two parts (dorsal and ven-
tral) and incubated for 60 min in PBS containing 0.5% trypsin with 5 mM 
EDTA (Invitrogen) to allow for separation of dermal and epidermal sheets. 
Epidermal and dermal sheets were then cut into small pieces and incubated 
for 2.5 h in collagenase D (1.6 mg/ml, working activity of 226 U/mg; 
Worthington) to obtain homogeneous cell suspension. The analysis of he-
matopoietic cell populations present in skin cell suspensions was assessed by 
fl  ow cytometry by gating on DAPI    –   CD45  +   cells. 
  Immunofl  uorescence analysis of mouse skin.     For staining of frozen sec-
tions, skin samples or skin DLNs were fi  rst fi  xed for 2 h in PBS 4% parafor-
maldehyde containing 20% sucrose to preserve EGFP fl  uorescence and were 
rinsed in PBS before freezing in optimum cutting temperature compound. 
8-     m-thick skin sections were prepared and stained with anti-langerin (poly-
clonal goat IgG; Santa Cruz Biotechnology) for 1 h, washed in PBS, and 
  incubated with secondary reagent donkey anti  –  goat Cy3 (Jackson Immuno-
research Laboratories). Skin DLN sections were fi  rst stained with anti-langerin 
(polyclonal goat IgG), followed by donkey anti  –  goat Cy3, and were stained 
after with biotinylated anti-B220 (RA3-6B2; BD Biosciences) revealed with 
streptavidin-Cy5 (Vector Laboratories). Slides were mounted with Vecta-
shield containing DAPI (4,6-diamidino-2-phenylindole; Vector Laborato-
ries). Images were acquired with a laser scanning confocal microscope 
(TCS-SP; Leica) and analyzed with Image J software (National   Institutes 
of Health). 
  Immunofl  uorescence analysis of cytospins.     Cytospins were prepared 
from 5  –  10,000 sorted cells, air-dried, and fi  xed in 3% paraformaldehyde. 
Slides were incubated with 0.8      g/ml anti-langerin goat polyclonal antibody or 
corresponding control (goat IgG; Sigma-Aldrich). For YAe staining, after block-
ing with 5      g/ml mouse IgG2b (eBioscience) and 2.5      g/ml anti-CD16/32 
to compare the nature of the antigen cargo displayed by these 
diff  erent sources of antigen-presenting cells in the skin DLNs to 
assess the immune relevance of each of these DC populations. 
  Our study also reports a striking diff  erence between the ho-
meostasis and traffi   cking pattern of LCs and dermal langerin  +   
DCs. After conditional ablation of langerin  +   DCs in vivo, we 
were surprised to discover that dermal langerin  +   DCs reappear 
in 5 d and start to emigrate to the skin DLNs and repopulate the 
langerin  +   DC pool immediately after, whereas LCs remained 
absent from the epidermis for   >  2 wk after their elimination. 
The constitutive recruitment of blood-derived langerin  +   DCs 
to the dermis, together with their rapid transit through the skin 
before reaching the skin DLNs, strongly support their role in 
skin immunosurveillance. This role is further supported by our 
fi  ndings showing that blood-derived dermal langerin  +   DCs cap-
ture and process skin-derived antigens before emigrating to the 
T cell areas of the skin DLNs, where they present skin-derived 
peptides in the context of MHC class II molecules. These fi  nd-
ings establish that, in addition to LCs and dermal langerin    –    DCs, 
an additional population of antigen-presenting cells may play a 
role in skin immunity. The expression of the langerin receptor 
on the surface of dermal DCs should allow the sampling of an-
tigen patterns by LCs, but not by dermal langerin    –    DCs. 
  Our results reveal a novel pathway of cutaneous DC dif-
ferentiation and homeostasis that add to the complexity of the 
DC network system developed to support skin immune re-
sponses (  Fig. 7  ).   We identifi  ed a population of circulating 
langerin  +   DCs, independent of LCs, that constitutively pa-
trols the dermis to capture and process skin antigens before 
emigrating to the skin DLNs, where they present skin-derived 
peptides  –  MHC complexes (  Fig. 7  ). This study uncovers a 
previously unappreciated element of skin immunosurveil-
lance that is likely to impact the design of vaccine strategies. 
    MATERIALS AND METHODS   
  Mice.     BALB/c, C57BL/6 (CD45.2  +  ), and congenic C57BL/6 CD45.1  +   mice 
5  –  8 wk of age were purchased from The Jackson Laboratory. Langerin-EGFP, 
Langerin-DTR/EGFP mice were generated as previously described (  18  ). 
CCR2-deficient C57BL/6 (  45  ) and CCR6-deficient C57BL/6 (  49  ), 
CD62L       /       (  50  ) and CCR7       /       (  30  ) (a gift from J. Lowe, Cleveland Clinic, 
Cleveland, OH), and P/E-selectin  –  defi  cient (P/E       /      ) mice (  51  ) (a gift from 
P. Frenette, Mount Sinai School of Medicine, New York, NY) were bred and 
maintained at our animal facility (Mount Sinai School of Medicine, New 
York, NY). CD45.1  +   Langerin-EGFP mice were generated by crossing of 
congenic C57BL/6 CD45.1  +   with CD45.2  +   Langerin-EGFP. C57BL/6 
BALB/c F1 and I-A  b     /      C57BL/6 BALB/c F1 were generated by breeding 
BALB/c with C57BL/6 or I-A  b     /      C57BL/6 (The Jackson Laboratory), 
  respectively. All mice used for experiments were between 8 and 12 wk of age. 
Parabiotic mice were generated as previously described (  36  ). Pairs of parabiotic 
mice consisted of congenic C57BL/6 CD45.1  +   mice linked to either C57BL/6 
CD45.2  +   or Langerin-DTR/EGFP C57BL/6 CD45.2  +   mice. Parabiotic mice 
were killed     2 mo after initiation of parabiosis and subjected to tissue analysis. 
To confi  rm effi   cient blood mixing in parabiotic mice, the percentage of 
CD45.1  +   and CD45.2  +   cells among blood leukocytes was analyzed in each 
animal. All animal protocols were approved by the Institutional Committee 
on Animal Welfare of the Mount Sinai Medical School. 
  Flow cytometry and cell sorting.     Multiparameter analyses of stained cell 
suspensions were made on an LSR II fl  ow cytometer (Becton Dickinson) and JEM VOL. 204, December 24, 2007 
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